These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 8312826

  • 1. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
    Kaulen P, Pham DT, Baranowski E, Wollensak J.
    Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
    [Abstract] [Full Text] [Related]

  • 2. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM, Bechtel LM, Starich GH.
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [Abstract] [Full Text] [Related]

  • 3. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 10 Suppl 1():S57. PubMed ID: 8595510
    [Abstract] [Full Text] [Related]

  • 4. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [Abstract] [Full Text] [Related]

  • 5. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G, Pontiggia P, Orbach-Arbouys S, Triana K, Ambetima N, Morette C, Hallard M, Blanquet D.
    Biomed Pharmacother; 1996 Feb; 50(5):220-7. PubMed ID: 8949403
    [Abstract] [Full Text] [Related]

  • 6. [AIDS: combination drug partner for AZT. HIV infection--new nucleoside analog].
    Böttger S.
    Fortschr Med; 1994 Oct 30; 112(30):50. PubMed ID: 7806121
    [No Abstract] [Full Text] [Related]

  • 7. ACTG 175 and Delta.
    Torres G.
    GMHC Treat Issues; 1995 Oct 30; 9(10):2-3. PubMed ID: 11362915
    [Abstract] [Full Text] [Related]

  • 8. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ, Bouza E, Antunes F, Smith D, Harris R, Warburg M, Walker M.
    Antivir Ther; 1997 Dec 30; 2(4):229-36. PubMed ID: 11327442
    [Abstract] [Full Text] [Related]

  • 9. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
    Ruiz-Argüelles GJ, Lagunes-Yannelli B, Mercado-Díaz L.
    Rev Invest Clin; 1993 Dec 30; 45(2):145-7. PubMed ID: 8393211
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 30; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 11. AZT delta study: major European/Australian study finds combinations better than AZT alone.
    King E.
    AIDS Treat News; 1995 Oct 06; (no 232):3-4. PubMed ID: 11362876
    [Abstract] [Full Text] [Related]

  • 12. [Antiretroviral treatment. Present and future of the combinations].
    Gatell-Artigas JM.
    Rev Neurol; 1996 Dec 06; 24(136):1627-31. PubMed ID: 9064189
    [Abstract] [Full Text] [Related]

  • 13. Studies confirm value of early and combination treatments.
    Vazquez E.
    Posit Aware; 1995 Dec 06; VI(6):8. PubMed ID: 11363148
    [Abstract] [Full Text] [Related]

  • 14. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug 06; 12(8):92-4. PubMed ID: 11364475
    [Abstract] [Full Text] [Related]

  • 15. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S, Badelon I, Chaine G.
    J Fr Ophtalmol; 1998 Jan 06; 21(1):34-41. PubMed ID: 9834898
    [Abstract] [Full Text] [Related]

  • 16. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS, Patel A.
    Indian J Ophthalmol; 2002 Mar 06; 50(1):29-33. PubMed ID: 12090084
    [Abstract] [Full Text] [Related]

  • 17. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK, Ricks MO, Forman MS, Jabs DA, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Clin Infect Dis; 2007 Apr 01; 44(7):1001-8. PubMed ID: 17342657
    [Abstract] [Full Text] [Related]

  • 18. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb 01; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 19. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan 01; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 20. [New treatments for HIV].
    Garcia E.
    Sidahora; 1996 Jan 01; ():48-50. PubMed ID: 11363630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.